These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2935552)

  • 1. Separation of human Glu-plasminogen, Lys-plasminogen and plasmin by high-performance affinity chromatography on Asahipak GS gel coupled with p-aminobenzamidine.
    Ito N; Noguchi K; Kazama M; Shimura K; Kasai K
    J Chromatogr; 1985 Nov; 348(1):199-204. PubMed ID: 2935552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance affinity chromatography of plasmin and plasminogen on a hydrophilic vinyl-polymer gel coupled with p-aminobenzamidine.
    Shimura K; Kazama M; Kasai K
    J Chromatogr; 1984 Jun; 292(2):369-82. PubMed ID: 6235238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance affinity chromatography of trypsins on Asahipak GS-gel coupled with p-aminobenzamidine.
    Ito N; Noguchi K; Shimura K; Kasai K
    J Chromatogr; 1985 Sep; 333(1):107-14. PubMed ID: 3934203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of the affinity chromatography forms of human Glu- and Lys-plasminogens and plasmins.
    Summaria L; Spitz F; Arzadon L; Boreisha IG; Robbins KC
    J Biol Chem; 1976 Jun; 251(12):3693-9. PubMed ID: 132440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of high-performance affinity chromatography and specific detection of proenzyme applicable to the analysis of the fibrinolytic system of human plasma.
    Ito N; Noguchi K; Kazama M; Shimura K; Kasai K
    J Chromatogr; 1987 Jan; 386():51-6. PubMed ID: 2951390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid and sensitive analytical procedure for human plasminogen subspecies. Combination of high-performance affinity chromatography and specific monitoring of proenzymes.
    Ito N; Abe I; Noguchi K; Kazama M; Shimura K; Kasai K
    Biochem Int; 1987 Aug; 15(2):311-9. PubMed ID: 2963638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Kunitz inhibitor binding domain in plasmin-derived light chain as shown by affinity chromatography.
    Chauvet J; Chabbat J; Acher R
    Int J Pept Protein Res; 1986 Jul; 28(1):85-90. PubMed ID: 2944852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Features of the interaction of Glu- and Lys-forms of plasminogen with native and partially hydrolyzed fibrin].
    Grinenko TV; Skomorovskaia EV; Kudinov SA; Zolotareva EN
    Biokhimiia; 1992 May; 57(5):728-37. PubMed ID: 1322196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of microplasminogen. A low molecular weight form of plasminogen.
    Shi GY; Wu HL
    J Biol Chem; 1988 Nov; 263(32):17071-5. PubMed ID: 2972717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and some properties of the Glu- and Lys-human plasmin heavy chains.
    Gonzalez-Gronow M; Violand BN; Castellino FJ
    J Biol Chem; 1977 Apr; 252(7):2175-7. PubMed ID: 139407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing the separation of glu-plasminogen affinity forms I and II by affinity chromatography.
    Traas DW; Hoegee-de Nobel B; Nieuwenhuizen W
    Thromb Haemost; 1984 Dec; 52(3):347-9. PubMed ID: 6531758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the purification and characterization of human urinary plasminogen and plasmin.
    Chen HF; Nakabayashi M; Satoh K; Sakamoto S
    Thromb Haemost; 1980 Feb; 42(5):1536-47. PubMed ID: 6445089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the isolation of the multiple molecular forms of human plasminogen and plasmin by isoelectric focusing methods.
    Summaria L; Arzadon L; Bernabe P; Robbins KC
    J Biol Chem; 1972 Jul; 247(14):4691-702. PubMed ID: 4261400
    [No Abstract]   [Full Text] [Related]  

  • 15. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
    Rouy D; Anglés-Cano E
    Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The isolation and characterization of a ternary human plasmin B-chain-streptokinase-plasminogen complex.
    Summaria L; Boreisha I; Barlow GH; Robbins KC
    Thromb Haemost; 1987 Aug; 58(2):772-7. PubMed ID: 2960030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifications to the lysine Sepharose method of plasminogen purification which ensure plasmin-free Glu-plasminogen.
    Grant AJ
    Biochem Int; 1990; 20(3):519-27. PubMed ID: 2140680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interaction of heavy and light chains of plasmin with fibrinogen E and D fragments].
    Kudinov SA; Lezhen TI
    Biokhimiia; 1984 Dec; 49(12):2003-7. PubMed ID: 6240993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
    Müllertz S; Thorsen S; Sottrup-Jensen L
    Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid and simple method for the separation of four molecular forms of human plasminogen.
    Nieuwenhuizen W; Traas DW
    Thromb Haemost; 1989 Apr; 61(2):208-10. PubMed ID: 2749595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.